Dr. Bijorn Omar Balzamino, PhD — Biologist and Researcher at the Fondazione G.B. Bietti IRCCS, Rome, Italy.
Education: PhD in Bioengineering and Biosciences (Curriculum in Biomedical Engineering), Università Campus Bio-Medico di Roma (2018).
Experience: With more than a decade of research experience bridging molecular and cellular biology, neurobiology, and ophthalmology, Dr. Balzamino has been part of the Fondazione Bietti Laboratory since 2010—first as a contract biologist and since 2018 as a permanent staff scientist. His work integrates retinal in vitro/ex vivo models, ocular fluid sampling devices, and multi-omics biomarker profiling to explore neuro-ophthalmological and neurodegenerative processes.
Memberships & Editorial Roles: Active reviewer and editorial board member in Frontiers Media SA (Loop Platform) and MDPI Journals, contributing to peer-review activities in translational ophthalmology, neurodegeneration, and molecular neuroscience.
Impact: Dr. Balzamino’s research advances understanding of glia–neuron cross-talk, neurotrophin signaling, oxidative stress, and inflammatory pathways in retinal and neurodegenerative diseases. His translational work on novel ocular sampling technologies and bioengineered diagnostic approaches provides reproducible models and standardized biomarker pipelines that help peers improve inter-study comparability, refine early-stage diagnostics, and accelerate cross-disciplinary neuro-ophthalmic research.
Dr. Bijorn Omar Balzamino, PhD — Biologist and Researcher at the Fondazione G.B. Bietti IRCCS, Rome, Italy.
Education: PhD in Bioengineering and Biosciences (Curriculum in Biomedical Engineering), Università Campus Bio-Medico di Roma (2018).
Experience: With more than a decade of research experience bridging molecular and cellular biology, neurobiology, and ophthalmology, Dr. Balzamino has been part of the Fondazione Bietti Laboratory since 2010—first as a contract biologist and since 2018 as a permanent staff scientist. His work integrates retinal in vitro/ex vivo models, ocular fluid sampling devices, and multi-omics biomarker profiling to explore neuro-ophthalmological and neurodegenerative processes.
Memberships & Editorial Roles: Active reviewer and editorial board member in Frontiers Media SA (Loop Platform) and MDPI Journals, contributing to peer-review activities in translational ophthalmology, neurodegeneration, and molecular neuroscience.
Impact: Dr. Balzamino’s research advances understanding of glia–neuron cross-talk, neurotrophin signaling, oxidative stress, and inflammatory pathways in retinal and neurodegenerative diseases. His translational work on novel ocular sampling technologies and bioengineered diagnostic approaches provides reproducible models and standardized biomarker pipelines that help peers improve inter-study comparability, refine early-stage diagnostics, and accelerate cross-disciplinary neuro-ophthalmic research.